An improved COVID-19 vaccine shows promise against Omicron i

In a recent study published in the journal Science Translational Medicine, researchers in the United States designed a bivalent coronavirus disease 2019 (COVID-19) vaccine on the messenger ribonucleic acid (mRNA) platform.

Related Keywords

United States , Syria , Wuhan , Hubei , China , Syrian , , Science Translational Medicine , Coronavirus Disease Covid 19 , Micron , Vaccine , Ntibody , Ntigen , Essay , Fell , Coronavirus , Efficacy , Nzyme , Immunity , Immunization , Lungs , Medicine , Anoparticle , Reclinical , Protein , Eceptor , Espiratory , Ibonucleic Acid , Cars , Ars Cov 2 , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , Yndrome ,